期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 -, 期 -, 页码 -出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c00710
关键词
-
This Review presents the most likely process-scale synthetic approaches to 44 new chemical entities approved for the first time anywhere in the world during 2020. These privileged structures with affinities for biological targets implicated in human diseases and conditions, particularly small molecules and antibody-drug conjugates (ADCs), provide insight into molecular recognition and serve as leads for future drug design.
New drugs introduced to the market are privileged structures that have affinities for biological targets implicated in human diseases and conditions. These new chemical entities (NCEs), particularly small molecules and antibody-drug con-jugates (ADCs), provide insight into molecular recognition and simultaneously function as leads for the design of future medicines. This Review is part of a continuing series presenting the most likely process-scale synthetic approaches to 44 new chemical entities approved for the first time anywhere in the world during 2020.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据